LAMIVUDINE (100MG OD) FOR 1-YEAR SIGNIFICANTLY IMPROVES NECRO-INFLAMMATORY ACTIVITY AND REDUCES PROGRESSION IN FIBROSIS STAGE - RESULTS OF A PLACEBO-CONTROLLED MULTICENTER STUDY IN ASIA OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION

LEUNG NWY LAI CL LIAW YF CHANG TT GUAN R TAI DI NG KY WU PC BARBER J DENG JC GRAY DF

Nwy. Leung et al., LAMIVUDINE (100MG OD) FOR 1-YEAR SIGNIFICANTLY IMPROVES NECRO-INFLAMMATORY ACTIVITY AND REDUCES PROGRESSION IN FIBROSIS STAGE - RESULTS OF A PLACEBO-CONTROLLED MULTICENTER STUDY IN ASIA OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION, Hepatology, 26(4), 1997, pp. 915-915

NO

Gastroenterology & Hepatology

Hepatology → ACNP

02709139

26

4

1997

2

S

915 - 915

ISI

0270-9139(1997)26:4<915:L(OF1S>2.0.ZU;2-2